Skip to main content
Fig. 3 | Insights into Imaging

Fig. 3

From: Development and external validation of a radiomics model for assessment of HER2 positivity in men and women presenting with gastric cancer

Fig. 3

Decision curves of the radiomics model in the training, internal validation, and external validation cohorts. The X-axis represents the threshold probability and the Y-axis is the net benefit. The black line “NONE” indicates that no lesions are assumed to be HER2-positive, and the gray line “ALL” indicates that all lesions are assumed to be HER2-positive. The model with higher clinical usefulness means it is further away from both the black and gray lines

Back to article page